Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 300Carcinoma, Non-Small-Cell Lung 246Prostatic Neoplasms 195Neoplasms 193Lung Neoplasms 151Multiple Myeloma 145Neoplasm Metastasis 110Colorectal Neoplasms 104Melanoma 97Ovarian Neoplasms 90Leukemia, Myeloid, Acute 85Pancreatic Neoplasms 75Lymphoma 75Leukemia, Lymphocytic, Chronic, B-Cell 74Brain Neoplasms 71Carcinoma, Renal Cell 67Carcinoma, Hepatocellular 62Squamous Cell Carcinoma of Head and Neck 61Lymphoma, Non-Hodgkin 60Hematologic Neoplasms 60Urinary Bladder Neoplasms 59Head and Neck Neoplasms 57Triple Negative Breast Neoplasms 55Glioblastoma 54Recurrence 52Lymphoma, Follicular 51Endometrial Neoplasms 50Uterine Cervical Neoplasms 49Stomach Neoplasms 46Sarcoma 46

Interventions

Positron-Emission Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Primary Ovarian Insufficiency × 90 days × Clear all
NCT05632601 2026-05-08

HER-CROWN

Ottawa Heart Institute Research Corporation

Phase NA Active not recruiting
176 enrolled
BreastGynecologic

Breast Neoplasms, Cardiovascular Diseases, Polycystic Ovary Syndrome, Toxemia, Diabetes, Gestational, Primary Ovarian Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡